Immutep (IMMP) EPS (Basic) (2016 - 2025)

Immutep filings provide 9 years of EPS (Basic) readings, the most recent being -$0.12 for Q2 2025.

  • On a quarterly basis, EPS (Basic) fell 38.98% to -$0.12 in Q2 2025 year-over-year; TTM through Dec 2025 was -$0.25, a 94.89% decrease, with the full-year FY2025 number at -$0.03, down 15.2% from a year prior.
  • EPS (Basic) hit -$0.12 in Q2 2025 for Immutep, down from -$0.05 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.0 in Q4 2023 to a low of -$0.12 in Q2 2025.
  • Median EPS (Basic) over the past 5 years was -$0.05 (2024), compared with a mean of -$0.05.
  • Biggest five-year swings in EPS (Basic): crashed 3744.69% in 2022 and later soared 107.35% in 2023.
  • Immutep's EPS (Basic) stood at $0.0 in 2021, then crashed by 3744.69% to -$0.06 in 2022, then soared by 107.35% to $0.0 in 2023, then plummeted by 1243.85% to -$0.05 in 2024, then crashed by 145.38% to -$0.12 in 2025.
  • The last three reported values for EPS (Basic) were -$0.12 (Q2 2025), -$0.05 (Q4 2024), and -$0.09 (Q2 2024) per Business Quant data.